HQH
Tekla Healthcare Investors
Price:  
15.67 
USD
Volume:  
354,548.00
United States | N/A
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HQH Relative Valuation

-30.3%
Upside

As of 2025-05-18, the Relative Valuation of Tekla Healthcare Investors (HQH) is 10.92 USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.67 USD, the upside of Tekla Healthcare Investors based on Relative Valuation is -30.3%.

The range of the Relative Valuation is 8.03 - 13.83 USD.

Range Selected
Trailing P/E multiples 7.7x - 13.2x 10.4x
Forward P/E multiples 10.0x - 16.7x 13.6x
Fair Price 8.03 - 13.83 10.92
Upside -48.7% - -11.8% -30.3%
15.67 USD
Stock Price
10.92 USD
Fair Price

HQH Relative Valuation - Historical P/E Data

Date P/E
2025-05-16 14.98
2025-05-15 14.77
2025-05-14 14.56
2025-05-13 14.69
2025-05-12 14.93
2025-05-09 14.53
2025-05-08 14.59
2025-05-07 14.75
2025-05-06 14.76
2025-05-05 15.60
2025-05-02 15.57
2025-05-01 15.36
2025-04-30 15.53
2025-04-29 15.39
2025-04-28 15.34
2025-04-25 15.30
2025-04-24 15.42
2025-04-23 15.09
2025-04-22 14.71
2025-04-21 14.48
2025-04-17 14.44
2025-04-16 14.45
2025-04-15 14.54
2025-04-14 14.46
2025-04-11 14.23
2025-04-10 13.70
2025-04-09 14.22
2025-04-08 13.52
2025-04-07 13.63
2025-04-04 14.21
2025-04-03 15.07
2025-04-02 15.19
2025-04-01 15.15
2025-03-31 15.53
2025-03-28 15.78
2025-03-27 15.77
2025-03-26 15.85
2025-03-25 15.79
2025-03-24 16.10
2025-03-21 15.99
2025-03-20 15.90
2025-03-19 15.90
2025-03-18 15.98
2025-03-17 16.08
2025-03-14 15.85
2025-03-13 15.82
2025-03-12 15.89
2025-03-11 15.80
2025-03-10 16.02
2025-03-07 16.30